Pulse 2.0

Galvanize Therapeutics Raises $130 Million Series D

Cover art for Galvanize Therapeutics Raises $130 Million Series D

TL;DR: Galvanize Therapeutics raised $130 million in Series D funding to commercialize its Aliya pulsed electric field platform and develop new applications in oncology and chronic disease. Galvanize Therapeutics secures $130M Series D to expand pulsed electric field ablation platform. Galvanize Therapeutics closed an oversubscribed $130 million Series D financing to expand commercial business, generate clinical evidence, and develop pulsed electric field technologies.

Amit ChowdhryNov 16, 2026

From · · · 1m

TL;DR: Galvanize Therapeutics Raises $130 Million Series D

Galvanize Therapeutics secures $130M Series D to expand pulsed electric field ablation platform.

Galvanize Therapeutics raised $130 million in Series D funding to commercialize its Aliya pulsed electric field platform and develop new applications in oncology and chronic disease. Galvanize Therapeutics secures $130M Series D to expand pulsed electric field ablation platform. Galvanize Therapeutics closed an oversubscribed $130 million Series D financing to expand commercial business, generate clinical evidence, and develop pulsed electric field technologies.

  • Funding Round
  • Investors
  • Leadership
  • Commercial Progress

Read the story version — the same reporting as a swipeable deck of 4 cards.

Read the original on Pulse 2.0

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on galvanize therapeutics and related topics.